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Abstract 22
Jembrana  Disease  Virus  (JDV)  is  an  unusual  bovine  lentivirus  that  causes  an  acute  and  23
sometimes fatal disease after a short incubation period in Bali cattle (Bos javanicus). The  24
pathological  changes  occur  primarily  in  lymphoid  tissues,  which  feature  proliferating  25
lymphoblastoid-like cells predominantly throughout parafollicular (T-cell) areas, and atrophy  26
of follicles (B-cell) areas. Five Bali cattle were experimentally infected with JDV and all  27
developed  typical  clinical  signs  of  Jembrana  disease  characterized  by  a  transient  febrile  28
response,  enlargement  of  superficial  lymph  nodes  and  a  significant  leukopenia.  Flow  29
cytometric  analysis  of  PBMC  during  the  acute  (febrile)  disease  phase  showed  that  the  30
reduced number of lymphocytes was due to a significant decrease in both the proportion and  31
absolute numbers of CD4
+ T cells, but not CD8
+ T-cells or CD21
+ B-cells. At the end of the  32
febrile phase, total numbers of both CD8
+ T-cells and CD21
+ B-cells increased significantly,  33
while  CD4
+  T-cell  numbers  remained  below  normal  values,  resulting  in  a  significantly  34
reduced  CD4
+:CD8
+  ratio.  We  speculate  that  the  persistent  depletion  of  CD4
+  T  cells  35
following JDV infection, through lack of CD4
+ T cell help to B cells, may explain the lack of  36
production of JDV-specific antibodies for several weeks after recovery despite an increase in  37
CD21
+ B cell numbers. Further, our previous data showing that IgG
+ plasma cells are targets  38
for JDV infection, correlated with our current data demonstrating an increase in CD8
+ T cell  39
numbers,  supports  the  suggestion  that  anti-viral  cytotoxic  T  cell  or  other  cell-mediated  40
immune  responses  may  be  critical  in  the  recovery  process,  although  this  remains  to  be  41
formally demonstrated for JDV. 42
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Introduction  53
Jembrana disease (JD) is an infectious disease of Bali cattle caused by Jembrana disease virus  54
(JDV), a pathogenic lentivirus most closely related to Bovine Immunodeficiency Virus (BIV)  55
(Chadwick et al., 1995). Infection of Bali cattle (Bos javanicus) with JDV causes an acute  56
disease  with  clinical  signs  including  fever,  lethargy,  anorexia  and  enlargement  of  the  57
superficial lymph nodes beginning 5-12 days after infection that resolves within 17 days  58
(Soeharsono et al., 1990; Soesanto et al., 1990; Wilcox et al., 1995). Hematological changes  59
during  the  acute  disease  include  leukopenia  as  a  result  of  a  lymphopenia,  eosinopenia,  60
neutropenia, thrombocytopenia, anemia, increased blood urea concentrations and diminished  61
total plasma protein concentration (Soesanto et al., 1990). Gross pathological changes include  62
vascular damage such as mild exudates and hemorrhages, but the most striking changes are  63
lymphadenopathy  and  splenomegaly.  Lymphoid  tissues  of  all  organs,  particularly  in  the  64
enlarged  lymph  nodes  and  spleen,  feature  proliferating  lymphoblastoid-like  cells  65
predominantly throughout parafollicular (T-cell) areas, and atrophy of follicles (B-cell areas).  66
A  proliferative  lymphoid  infiltrate  is  also  found  in  the  parenchyma  of  most  organs,  67
particularly the liver and kidneys and an infiltrate containing proliferative macrophage-like  68
cells is found in the lungs (Dharma et al., 1991). 69
70
In experimentally infected cattle, the case fatality rate was originally estimated to be 17%  71
(Soeharsono et al., 1990) but was more recently reported to be 11.5% (Desport et al., 2009a).  72
For naturally infected animals the case fatality rates vary: a mortality rate of 98.9% was  73
reported during the first outbreak in 1962 however in more recent outbreaks mortality rates  74
have varied from 20 – 37% in a new areas where JDV has not been previously reported  75
(Ramachandran et al., 1996). During the acute phase, a high titer of virus (~10
10RNA genome  76
copies/ml plasma) is present in the plasma, persisting at low levels for at least 25 months  77Page 5 of 34
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after recovery from the acute disease (Soeharsono et al., 1990; Stewart et al., 2005). The  78
experimentally infected Bali cattle that survive the acute clinical disease do not develop any  79
further clinical disease (Soeharsono et al., 1990; Soesanto et al., 1990) and resist re-infection  80
(Soeharsono et al., 1990) but the immune mechanism responsible for recovery from the acute  81
disease and continued immunity has not been defined. Although not formally proven, there is  82
circumstantial evidence to suggest that neutralizing antibody does not play a major role in  83
recovery as JDV-specific antibodies are not detectable until some weeks after recovery from  84
the acute disease (Hartaningsih et al., 1994). This has lead to the hypothesis that cellular  85
immune  responses,  presumably  through  IFN-mediated  activation  of  viral-specific  CD8
+  86
cytotoxic T lymphocytes, play a critical role in recovery from JDV infection, as is the case  87
for equine infectious anemia virus (EIAV) (Murakami et al., 1999) and HIV (Migueles and  88
Connors, 2002), although again this remains to be formally proven for JDV. 89
90
Hyperplasia of T-cell areas and depletion of B-cell areas of lymphoid tissues during acute  91
Jembrana disease is a hallmark of the disease (Dharma et al., 1991). Depletion of lymphocyte 92
[the CD4
+ T-cell and CD8
+ T-cell] populations was observed histologically in JDV-infected  93
Bali  cattle  and  significant  differences  were  found  during  acute  illness  in  follicular  94
compartments of lymph nodes (Dharma et al., 1994). The acute febrile phase of Jembrana  95
disease is characterised by marked haematological changes that include leucopenia due to  96
lymphopenia, eosinopenia, and a slight neutropenia and thrombocytopenia (Soesanto et al.,  97
1990). The  mechanism  for  the  changes  in  lymphocyte  populations  in  Jembrana  disease  98
remains unknown. It was suggested that the gradual depletion of CD4
+ T-cells may have been  99
due to infection of T-cells (Dharma et al., 1994). Although T-cells are the predominant target  100
cell of some lentiviruses, including HIV (Alcami, 2004; Blankson et al., 2002; Brenchley et  101
al., 2004; Clapham and McKnight, 2001), SIV (Brown et al., 2007; Mattapallil et al., 2005;  102Page 6 of 34
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Picker, 2006) and FIV (Ackley et al., 1990), there is no evidence for infection of CD3
+ T- 103
cells  or  MAC387
+  monocytes  by  JDV  and  the  target  virus  infection  was  identified  in  104
lymphoid  tissues  as  pleomorphic  centroblast-like  cells  which  were  identified  as  IgG- 105
containing cells, including plasma cells (Desport et al., 2009b).  106
107
Although lymphopenia is a characteristic feature of Jembrana disease (Soesanto et al., 1990),  108
changes  in  circulating  lymphocyte  subsets  during  the  acute  disease  have  remained 109
uncharacterized. We report a flow cytometric analysis of the circulating CD4
+ T cell, CD8
+ T  110
cell and CD21
+ B cell populations during the febrile and early post-febrile phases undertaken  111
to  better  understand  the  acute  disease  process  associated  with  JDV  infection. Our  data  112
indicate that shortly after the end of febrile periods (9 days after infection), CD8
+ T cell  113
numbers were elevated and this coincided with increased of INF expression.  Given that  114
antibodies were not detected until several weeks after the initial infections, this data may  115
explain  why  the  majority  (80%)  of  experimentally  JDV-infected  animals  survived  and  116
support the conclusion that CD8
+ T cell-mediated protection is important in recovery from  117
JDV infection. 118
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Materials and Methods  119
120
Experimental animals and sample collection 121
Bali cattle used in the experimental studies were female, approximately 12 months of age and  122
weighed 80-100 kg. They were obtained from Nusa Penida, a small island adjacent to Bali,  123
where Jembrana disease has never been reported and where antibodies to JDV have not been  124
detected  (Hartaningsih  et  al.,  1994).  Cattle  purchased  from  the  island  have  consistently  125
developed clinical signs of Jembrana disease when infected with JDV (Soeharsono et al.,  126
1990).  Animals  for  these  experiments  were  transported  to  Bali  island  to  the  Disease  127
Investigation  Centre  Region  VI,  Denpasar,  Bali.  On  arrival,  they  were  sprayed  with  128
insecticide, kept in an insect-proof house and given water and elephant grass (Penecetum  129
purpureum)  ad  libitum.  Prior  to  use,  all  cattle  were  pre-treated  with  a  broad  spectrum  130
antibiotic (oxytetracycline) at a dose rate of 5 mg/kg bodyweight for 3 consecutive days, a  131
broad spectrum anti-helmintic, and they were vaccinated against haemorrhagic septicaemia.   132
Before inoculation with JDV, the absence of antibody to JDV was confirmed by ELISA test  133
using a JDV recombinant CA antigen as described previously (Burkala et al., 1998). 134
135
Five Bali cattle were infected intravenously with an estimated 100 infectious doses of JDV  136
contained in a 10% homogenate in Dulbecco’s modified Eagle’s medium of spleen which had  137
been stored at −70 °C and previously prepared from an animal experimentally infected with  138
JDVTab87 (Soeharsono et al., 1995). The febrile phase in the inoculated animals occurred from  139
5-11 days after infection. Blood samples were analysed prior to infection (day 0), at day 2  140
and daily from days 4 to 7 (febrile phase) and day 9 post-infection, and then finally at day 19 141
when the animals were euthanased for autopsy. Sterile EDTA-containing vacutainer tubes  142
(Greiner Bio-One) were used to collect blood samples for recovery of lymphocytes.  143Page 8 of 34
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144
Lymphocyte preparation 145
Peripheral blood mononuclear cells were isolated using Ficoll-Paque plus density separation  146
(Amersham Biosciences, Australia) following the manufacturer’s instructions, then washed  147
twice in FACS (fluorescence-activated cell sorting) buffer (Dulbecco’s phosphate-buffered  148
saline  [Thermo  Scientific]  supplemented  with  5%  heat  inactivated  FCS  (Bovogen  149
Biologicals, Australia) and 0.05% sodium azide (Sigma-Aldrich, Australia). The washed cells  150
were then resuspended in FACS buffer and adjusted to a density of 1 x 10
7 cells/ml, and kept  151
at 5
oC until they were immunolabeled on the same day. Total white blood cells were counted  152
using trypan blue  staining  and a  haemocytometer. Absolute  numbers lymphocyte subsets  153
were calculated by multiplying the total lymphocyte count by the proportion of CD4
+, CD8
+ 154
or CD21
+ cells as determined by flow cytometry (see below). 155
156
Antibodies and cellular markers  157
Lymphocyte subsets were labeled  with 2.5 g/ml mouse anti-bovine CD4 mAb (Serotec,  158
UK), 5 g/ml mouse anti-bovine CD8 mAb (Serotec, UK) or 20 g/ml mouse anti-bovine  159
CD21 mAb (Santa Cruz, USA) as a B-cell marker. An Alexa Fluor 488 (AF488) conjugated  160
goat anti-mouse cross-absorbed secondary antibody (Invitrogen, Australia) was used to detect  161
all reactive mAb antibodies (Table 1). 162
163
Cell surface labeling of lymphocytes 164
Due to Australian quarantine and logistical requirements, peripheral blood lymphocytes were  165
antibody-labeled and fixed on-site in Bali prior to transport to Australia for analysis by flow  166
cytometry  at  the  University  of  Western  Australia,  using  a  previously  validated  protocol 167
(Foster et al., 2007; Rocchi et al., 2007) with slight modification. Following lymphocyte  168Page 9 of 34
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preparation,  1  ml  of  the  lymphocyte  suspension  was  incubated  with  100  l  of  primary  169
antibody in FACS buffer for 30 minutes at 4
oC, followed by 3 washes with FACS buffer (by  170
centrifugation for 1 min at 479 g at 4
oC). Secondary antibody (100 l) diluted in FACS buffer  171
was applied and incubated for 30 minutes at 4
oC in the dark. The cell suspensions were then  172
gently washed 3 times in FACS buffer, then washed once with PBS and the cells resuspended  173
in 200 l of fixation buffer (Dulbecco’s phosphate-buffered saline supplemented with 4%  174
paraformaldehyde) for 5 minutes at 37
oC. Finally, the cells were washed with 200 l of ice- 175
cold  Dulbecco’s  phosphate-buffered  saline  supplemented  with  1%  BSA  (Sigma  Aldrich,  176
Australia)  and  resuspended  in  1  ml  of  freezing  medium  (Dulbecco’s  phosphate-buffered  177
saline supplemented with 1% BSA and 10% dimethyl sulfoxide (Sigma Aldrich, Australia)  178
before being transferred to freezing vials and then stored at -80
oC. Samples were stored for  179
up to 2 months in Bali prior to transport to Australia for analysis by flow cytometry. 180
181
Flow cytometric analysis 182
Prior to flow cytometric analysis, cryopreserved lymphocyte samples were thawed rapidly at  183
37
oC in a water bath, then washed once with wash buffer (Dulbecco’s phosphate-buffered  184
saline supplemented with 0.1% BSA) and resuspended in 1 ml of labeling buffer (Dulbecco’s  185
phosphate-buffered saline supplemented with 10% heat-inactivated FCS and 0.1% sodium  186
azide  [Sigma  Aldrich]).  The  immunolabeled  samples  were  analyzed  using  a  BD  FACS  187
Calibur  flow  cytometer  (BD  Bioscience,  Australia)  with  a  488  nm  excitation  laser.  188
Lymphocytes  were  gated  in  a  forward  scatter/side  scatter  plot  (FSC-H  vs  SSC-H).  A  189
bandpass-specific  filter  (FL1,  530/30  nm)  was  used  for  Alexa  Fluor  488  emission  and  190
acquired in the logarithmic scale. A minimum of 10,000 lymphocytes were examined per  191
sample and an AF488 fluorescence histogram was used to compare the samples. Sample data  192
were  analyzed  using  BD  CellQuest  Pro  V5.2  (BD  Biosciences,  Australia)  which  is  the  193Page 10 of 34
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standard  operating  software  on  the  FACSCalibur.  Experimental  data  were  analyzed  and  194
population statistics calculated using FlowJo V7.2.5 (Tree Star Inc., USA) flow cytometric  195
analysis software. 196
197
Statistical analysis 198
The absolute numbers of lymphocyte subsets were calculated by multiplying the percentage  199
of each lymphocyte subset obtained from flow cytometric analysis with the total lymphocyte  200
counts/ml, and were reported as a mean ± standard deviation (SD). A one-way ANOVA  201
(SPSS® 17.0) was used to assess group differences in the lymphocyte populations, while  202
differences between time points during infection were analyzed using Bonferroni’s multiple  203
comparison. Significant differences in the mean values at different time points was analysed  204
by Tukey’s HSD test. A value of p<0.05 was considered significant for all analyses. 205
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Results 206
207
Flow cytometric analyses of lymphocyte subset changes following JDV infection 208
Prior to further analysis, sample preparation techniques were evaluated to assess the quality  209
of  lymphocytes  in  PBMC  isolated  using  Ficoll-Paque  at  various  time  points  following  210
experimental JDV infection of cattle. All samples were shown to have high viabilities, with  211
less than 5% dead cells as assessed by trypan blue staining (data not shown). Using flow  212
cytometry  gating  for  lymphocytes  (Figure  1)  and  labeling  for  CD4
+,  CD8
+  and  CD21
+ 213
lymphocyte  subsets  (Figures  2  to  4),  combined  with  total  cell  counts  for  assessment  of  214
absolute numbers of lymphocyte subsets, a significant differences in the total numbers of  215
lymphocyte subsets was observed at the 3 major time points of JDV infection: pre-infection  216
(day 0 prior to JDV infection), during the febrile phase (day 9) and during the immediate  217
post-febrile phase (day 19). 218
219
During the febrile and early recovery phases, the total number of CD4
+ T-cells decreased  220
significantly (Table 2 and Figure 5) and the percentage of CD4
+ T cells remained below  221
normal values until well after the febrile phase and into the early recovery phase (Figure 2). 222
Conversely, the total number of CD8
+ T-cells was reduced slightly during the febrile period  223
but increased significantly (p<0.001) above normal values in the early recovery phase (Table  224
2 and Figure 5). This corresponded to a slight decrease in the percentage of CD8
+ T cells  225
amongst PBMC during the febrile and early recovery phases compared to pre-infected cattle  226
(Figure 3). 227
228
Due to the dramatic depletion of CD4
+ T-cells and significant increase in CD8
+ T-cells after  229
JDV infection, the CD4
+:CD8
+ T-cell ratio also decreased significantly (p<0.05) from 0.5:1 at  230Page 12 of 34
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pre-infection to 0.25:1 and 0.01:1 during the febrile phase and post-febrile phase, respectively  231
(Table 3).  232
233
Total numbers of CD21
+ B-cells increased slightly during the febrile phase then increased  234
significantly  (p<0.001)  during  the  early  recovery  phase  (Table  2  and  Figure  5).  This  235
corresponded with an increase in the percentage of CD21
+ B cells during the febrile and early  236
recovery phases (Figure 4).  237
238
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Discussion 239
The nature of the response of Bali cattle to JDV infection, an acute disease process with a  240
short incubation period, a case fatality rate of about 17% and no recurrence of disease in  241
those animals that recover, is unusual for a lentivirus. The lack of any recurrence of disease in  242
animals that recover suggests the development of a strong protective immunity. The absence  243
of JDV-specific antibody until at least 5 weeks and not in most cattle until 11 weeks after  244
infection  (Hartaningsih et  al., 1994) implies  that  cell-mediated immune  responses  play a  245
major role in the recovery of the infected animals and probably in their continuing immunity.  246
The current study assessed  the responses of peripheral blood lymphocyte subsets to JDV  247
infection  in  experimentally  infected  animals  to  gain  insights  into  the  kinetics  of  the  248
lymphocyte response following infection. 249
250
The use of flow cytometric analysis confirmed the previous report of the significant decrease  251
in CD4
+: CD8
+ T-cell ratio of lymphocytes in lymphoid tissues during the acute phase of  252
Jembrana  disease  but  not  during  early  post-febrile  stages  (Dharma  et  al.,  1994).  In  this  253
current study, both CD4
+ and CD8
+ T-cells in peripheral blood significantly decreased during  254
the febrile phase compared to before infection, and this period corresponds to the duration of  255
the  lymphopenia  reported  during  the  febrile  phase  of  Jembrana  disease  (Soesanto  et  al.,  256
1990). The number of CD8
+ T-cells remained greater than CD4
+ T-cells during the febrile  257
phase but increased markedly during the post-febrile phase. Due to the significant increase of  258
CD8
+ T-cell numbers at the end of the febrile phase and a continuous depletion of CD4
+ T- 259
cells, this resulted in a dramatic decrease in the CD4
+:CD8
+ T-cell ratio during the post- 260
febrile phase. 261
262Page 14 of 34
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The  significant  increase  in  the  CD8
+  T-cell  population  after  the  febrile  phase  strongly  263
correlated with the expansion of CD3
+ T-cell numbers previously found in lymphoid tissues  264
during  this  stage  (Desport  et  al.,  2009a).  This  positive  correlation  may indicate  that  the  265
majority of the CD3
+ T-cells were CD8
+ T-cell subsets. Further, the increased population of  266
CD8
+ T-cells during JDV infection, in the absence of JDV-specific antibody until several  267
weeks after JDV-infection (Hartaningsih et al., 1994), provides additional support for the role  268
of these cells in the recovery from the acute disease process. Virus-specific CD8
+ cytotoxic  269
T-cells may play an important role in host defence against lentivirus infections (Levy, 1993;  270
Salk et al., 1993). The antiviral role of CD8
+ cytotoxic T lymphocytes has been considered to  271
be  important  in  the  inhibition  of  the  progression  of  early  EIAV  infection  before  the  272
production  of  virus  neutralizing  antibody  (Hammond  et  al., 1997;  McGuire  et  al., 2004;  273
McGuire  et al., 1994). It is also  thought to be important in non-progressor HIV-infected  274
individuals (Cao et al., 1995; Migueles et al., 2002), and in controlling SIV replication and  275
protection against SIV challenge (Genesca et al., 2009; Genesca et al., 2008; Jin et al., 1999).  276
It  is  only  in  the  transition  to  chronic  infection  that  the  impressive  early  potency  of  the  277
antiviral CD8
+ cytotoxic T-cells may wane (Pantaleo et al., 1997), which has been linked  278
with declining CD8
+ T cell function and the inability of the immune system to control viral  279
replication and spread of the virus (Migueles et al., 2002; Pantaleo et al., 1997; Zhang et al.,  280
2003). As with other lentivirus infections, at least during acute infections, the results of this  281
study  tend  to  support  the  current  hypothesis  that  virus-specific  CD8
+  cytotoxic  T  282
lymphocytes  may  play a  crucial  role  in  host  defence  against  lentivirus  infections (Levy,  283
1993), also supported by preliminary data showing elevated IFN mRNA during the recovery  284
phase (MT, PS, GW unpublished observations), however the specificity and anti-viral activity  285
of the CD8
+ T cell response for JDV remains to be determined. 286
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It is unclear why CD4
+ T-cells were dramatically decreased despite the absence of infection  288
of  T-cells  by  the  virus,  as  shown  in  previous  studies  (Desport  et  al.,  2009b)  and  again  289
confirmed in this study by immunohistochemistry (by co-staining lymphoid tissue with anti- 290
CD3 and anti-JDV capsid protein mAb) and by in situ hybridization for JDV RNA (data not  291
shown). A gradual depletion of CD4
+ T-cell subsets is associated with infection with the T- 292
cell tropic lentiviruses HIV (Alcami, 2004; Blankson et al., 2002; Brenchley et al., 2004;  293
Clapham and McKnight, 2001), SIV (Brown et al., 2007; Mattapallil et al., 2005; Picker,  294
2006) and FIV (Ackley et al., 1990). However, reduction of CD4
+ T-cell populations is not  295
always related to their infection by viruses. In EIAV infections, for example, both circulating  296
CD4
+ and CD8
+ T-cell  subsets  are reduced  significantly during acute infection, although  297
mature macrophages and not T-cells are the main target cells of the virus (Cook et al., 2001;  298
Murakami et al., 1999; Oaks et al., 1998; Sellon et al., 1992). In EIAV infection, depletion of  299
the T-cell subsets is possibly an indirect effect of the virus infection or virus components  300
(Murakami et al., 1999).  This so-called “bystander” depletion has also been observed in  301
uninfected  CD4
+  T  cells  HIV  infection,  where  induction  of  cell-surface  pro-apoptotic  302
molecules  such  as  Fas/FasL,  viral  proteins  and  undefined  soluble  mediators  have  been  303
implicated (Arokium et al., 2009; Ji et al., 2007; Holm and Gabuzda, 2005). 304
305
The population of CD21
+ B-cells increased prior to the febrile phase, indicating a transient  306
proliferation of  B-cells  or release of  B-cells  into  the  peripheral  blood during this phase,  307
similar to that reported during BIV infection (Whetstone et al., 1997). The reason for this is  308
unknown but in HIV-1, a putative polyclonal B-cell stimulatory epitope has been found in the  309
carboxyl  end  of  the  envelope  glycoprotein  of  the  virus,  specifically  associated  with  Nef  310
(Chirmule  et  al.,  1994).  Tmx,  an  accessory  protein  of  unknown  function  in  bovine  311
lentiviruses, is expressed at a similar region of the genome as nef. (Chadwick et al., 1995;  312Page 16 of 34
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Gonda  et  al.,  1990).  Nef  is  multifunctional,  but  mainly  responsible  for  viral  infectivity  313
(Brugger et al., 2007; Marsh, 1999; Qi and Aiken, 2008; Sol-Foulon et al., 2004). Although  314
the nef gene is not present  in the bovine lentiviruses, they have a tmx gene in a similar  315
location to nef, and 2 unique genes vpw and vpy that seem to be analogous to the vpr and  316
vpu/vpx genes of  primate  lentiviruses (Garvey et al., 1990).  Tmx may be involved in a  317
manner similar to Nef in the proliferation of B-cells in vivo, however this hypothesis would  318
need to be confirmed. During the febrile phase, there was a progressive reduction in the  319
numbers of CD21
+ B-cells which may be associated with replication of virus in these cells.  320
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Conclusions 321
The present  study has  clearly demonstrated  dramatic changes in the population of T-cell  322
subsets and B-cells during the course of Jembrana disease. A striking finding was that, during  323
the  febrile  and  early  recovery  phases,  the  total  number  of  CD4
+  T-cells  decreased  324
significantly and the percentage of CD4
+ T cells remained below normal values until well  325
after the febrile phase and into the early recovery phase. CD21
+ B-cells, possibly mature  326
JDV-specific B-cells that host viral replication, increased in peripheral blood prior to the  327
onset of the febrile phase and then declined in numbers and this decline corresponded to the  328
decrease in numbers of these cells in tissues during the febrile phase of the disease. CD8
+ T- 329
cell numbers increased during the acute disease and may well play a role in the recovery  330
process before the production of anti-viral antibody. 331
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Figure Captions 484
485
Figure 1.  Representative forward scatter and side scatter gating of PBMC used to identify  486
lymphocytes and their subsets by flow cytometry. Peripheral blood was isolated from cattle  487
on day 0 (pre-infection) and at days 10 (acute phase) and 19 (recovery phase) following  488
experimental  JDV  infection  and  PBMC  isolated  by  Ficoll-Paque  density  separation.  489
Following lymphocyte subset labeling (see following figures), cell suspensions were analysed  490
by  flow  cytometry  and  FSC  and  SSC  gates  set  as  indicated  for  subsequent  lymphocyte  491
analysis. One typical representative of 5 cattle is shown for each time point. 492
493
Figure 2. Flow cytometric analysis of CD4
+ T-cells following JDV infection. PBMC were  494
isolated at days 0, 10 and 19 post-infection and labeled with an anti-CD4-AF488 mAb. Cells  495
were gated by flow cytometry for lymphocytes as described in Figure 1, and fluorescence  496
histograms  shown  for  representative  cattle  C5  (left)  and  C7  (right)  demonstrating  a  497
significant reduction in the percentage proportion of CD4
+ T-cells from pre-infection through  498
the  acute  and  early  recovery  phases.  For  each  histogram,  CD4-AF488  immunolabeled  499
samples (thick black line) are compared to a non-labeled sample (thin black line). 500
501
Figure 3. Flow cytometric analysis of CD8
+ T-cells following JDV infection. PBMC were  502
isolated at days 0, 10 and 19 post-infection and labeled with an anti-CD8-AF488 mAb. Cells  503
were gated by flow cytometry for lymphocytes as described in Figure 1, and fluorescence  504
histograms shown for representative cattle C5 (left) and C7 (right), demonstrating a minor  505
decrease in the percentage proportion of CD8
+ T-cells from pre-infection through the acute  506
and early recovery phases. For each histogram, CD8-AF488 immunolabeled samples (thick  507
black line) are compared to a non-labeled sample (thin black line). 508Page 26 of 34
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509
Figure 4. Flow cytometric analysis of CD21
+ B-cells following JDV infection. PBMC were  510
isolated at days 0, 10 and 19 post-infection and labeled with an anti-CD21-AF488 mAb.  511
Lymphocytes were gated as described in Figure 1, and fluorescence histograms shown for  512
representative cattle C5 (left) and C7 (right) demonstrating an increase in the percentage  513
proportion of CD21
+ B-cells from pre-infection through the acute and early recovery phases.  514
For each histogram, CD21-AF488 immunolabeled samples (thick black line) are compared to  515
a non-labeled sample (thin black line). 516
517
Figure  5.  Lymphocyte  subset  changes  related  to  the  febrile  response  following  JDV  518
infection. PBMC were isolated at the indicated time points following JDV infection, labeled  519
with AF-488 conjugated mAbs to CD4, CD8 and CD21 and the percentage proportion of  520
lymphocyte subsets analysed by flow cytometry as described in Figures 1 to 4 above. This  521
percentage data was then converted to a total lymphocyte count per ml of blood as described  522
in  Materials  and  Methods  and  plotted  against  rectal  temperatures  measured  at  the  523
corresponding time points. Data presented are means of values from 5 animals ± SD. 524
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Table  1.  Primary and  secondary  antibodies  used  for  flow  cytometric  analysis  of  525
lymphocytes from cattle infected with JDV. 526
Antibody Source Isotype/clone Cat./Lot No
Primary antibody
Mouse anti-bovine CD4 Serotec IgG2a/CC8 MCA1653G
Mouse anti-bovine CD8 Serotec IgG2a/CC63 MCA1653G
Mouse anti-bovine CD21 Santa Cruz   IgG2b/CC51 SC-101835
Secondary antibody
Goat anti-mouse Invitrogen Alexa Fluor 488 A-11029
527
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Table 2. Comparison of lymphocyte subsets during 3 major phases after JDV infection.  528
Mean absolute number cells/ml± SD
Lymphocyte population
Pre-infection Febrile phase Post-febrile phase
T-helper cells, CD4
+ 2418 ±277
a 176± 171
b 45 ±10
 b
Cytotoxic T-cells, CD8
+ 1210±206
 b 768±489
b 3187±601
 a
B-cells, CD21
+ 1799 ± 404
 b 2065±823
b 4225 ± 841
 a
Means in a row with different superscripts are significantly different by Tukey’s HSD 529
(p<0.05). 530
531
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Table 3. Changes in CD4
+:CD8
+ T-cell ratio during the course of JDV infection. 532
Days  after 
infection
Mean CD4
+ 
(number/ml)
SD Mean CD8
+ 
(number/ml)
SD CD4
+:CD8
+
ratio
0 2418 713 1210 14 0.5:1
2 248 11 869 12 0.28:1
4 217 8 740 12 0.29:1
5 274 24 1236 31 0.22:1
6 229 18 605 18 0.38:1
7 138 11 367 11 0.37:1
9 28 0.4 709 21 0.04:1
19 36 0.2 3187 32 0.01:1
533
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Figure 5